Today: 12 June 2026
Browse Category

NASDAQ:MCRS 10 September 2025

Engineered Living Therapeutics: How “Bugs as Drugs” Are Transforming Medicine in 2025

Engineered Living Therapeutics: How “Bugs as Drugs” Are Transforming Medicine in 2025

Regulators approved the first microbiome-based therapies for infection in 2022–2023, including Rebyota and Vowst. Next-generation engineered microbes are now in clinical trials for cancer, metabolic, and immune disorders. Synthetic biology advances enable microbes to sense and respond inside the body. Major biotech firms and pharma are investing, with positive Phase 3 results reported for some live microbe therapies in 2025.
10 September 2025
·

Stock Market Today

  • IREN Shares Rise Amid AI Cloud Focus and Funding Update
    June 12, 2026, 10:10 AM EDT. IREN shares jumped to $56.71, up $5.16, as investors reassessed its pivot from Bitcoin mining to AI cloud infrastructure. Analyst Needham lowered 2026-27 revenue forecasts, citing slower AI cloud growth but expects $3.7 billion annualized run rate by early 2027. IREN secured $3.65 billion in financing tied to its Microsoft AI cloud contract, covering most GPU-related capital expenditure. The company is expanding with an 800MW data center in South Australia aimed at the Asia-Pacific market, powered by clean energy and submarine fiber. Investors highlight IREN's strategic positioning with high-demand GPU compute and major clients like Nvidia, despite timing uncertainties around AI revenue ramp-up.

Latest articles

SharonAI Stock Jumps as Nvidia Deal Puts $4.88 Billion AI Cloud Bet in Focus

SharonAI Stock Jumps as Nvidia Deal Puts $4.88 Billion AI Cloud Bet in Focus

12 June 2026
SharonAI shares surged after announcing a six-year, $4.88 billion NVIDIA collaboration for up to 40,000 Grace Blackwell GPUs and 72MW of new AI data-center capacity in Australia, but the company remains unprofitable, faces key execution and financing risks, and analysts’ average price target of $65 is below the recent $71.51 quote.
T3 Defense Sees Stock Shift as CFO Starts Ahead of Nasdaq Vote

T3 Defense Sees Stock Shift as CFO Starts Ahead of Nasdaq Vote

12 June 2026
T3 Defense named Roy Cohen CFO just days before a crucial June 18 shareholder vote on major share issuances and a possible reverse stock split, as DFNS stock rebounded pre-market after closing Thursday at $0.2566, down 6.72%; the outcome could impact dilution risk and the company’s ability to meet Nasdaq’s $1 minimum bid requirement.
IREN Bounces After Needham Cuts Targets, Market Watches AI Cloud Moves

IREN Shares Bounce While Investors Assess AI Cloud Prospects, Ongoing Funding Concerns

12 June 2026
IREN surged $5.16 to $56.71 after a volatile week, as investors weighed Needham’s cut to 2026-27 estimates on delayed AI cloud revenue ramp, with mining revenue expected to approach zero by year-end as GPU deployments replace Bitcoin capacity; the next key catalyst is proof of billable AI cloud revenue ahead of the September 16 earnings update.
Go toTop